Literature DB >> 16877347

Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

Seiji Goda1, Hiroshi Inoue, Hisanori Umehara, Michihiko Miyaji, Yutaka Nagano, Nari Harakawa, Hisao Imai, Peter Lee, James B Macarthy, Takashi Ikeo, Naochika Domae, Yoji Shimizu, Joji Iida.   

Abstract

Natural killer (NK) cells play a key role in inflammation and tumor regression through their ability to migrate into tissues. CXCL12 is a chemokine that promotes lymphocyte invasion and migration into tissues; however, the mechanism for this process remains incompletely understood. In this study, we show that CXCL12 significantly enhanced CD16(+)CD56(+) human peripheral NK-cell invasion into type I collagen by the catalytic activity of matrix metalloproteinase-1 (MMP-1). Confocal immunofluorescence and co-immunoprecipitation studies suggest that MMP-1 colocalized with alpha(2)beta(1) integrin on CXCL-12-stimulated NK-cell surface. The binding of pro-MMP-1 with alpha(2)beta(1) integrin required activation of G(i)-coupled pathway. However, the production of MMP-1 from CXCL12-stimulated NK cells was mediated by p38 and mitogen-activated or extracellular signal-regulation protein kinase kinase 1/2 in a manner independent of the G(i)-coupled pathway. These results suggest that CXCL12/CXCR4 interaction transduces the two signaling pathways to promote NK-cell invasion, which stimulates pericellular degradation of extracellular matrix proteins by membrane-associated MMP-1. The mechanisms would thus play a role in facilitating lymphocyte trafficking and accumulation in tissues during physiological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877347      PMCID: PMC1698790          DOI: 10.2353/ajpath.2006.050676

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Matrix metalloproteinases: effectors of development and normal physiology.

Authors:  T H Vu; Z Werb
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

2.  Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors.

Authors:  M H Kim; R P Kitson; P Albertsson; U Nannmark; P H Basse; P J Kuppen; M E Hokland; R H Goldfarb
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

3.  Expression and regulation of chemokine receptors in human natural killer cells.

Authors:  M Inngjerdingen; B Damaj; A A Maghazachi
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 4.  Interstitial collagenases as markers of tumor progression.

Authors:  C E Brinckerhoff; J L Rutter; U Benbow
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

Review 5.  Matrix metalloproteinases: multifunctional contributors to tumor progression.

Authors:  L J McCawley; L M Matrisian
Journal:  Mol Med Today       Date:  2000-04

Review 6.  Molecular signaling mechanisms of cell migration and invasion.

Authors:  D G Stupack; S Y Cho; R L Klemke
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

7.  CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.

Authors:  Tianqian Zhang; Rajasekharan Somasundaram; Klara Berencsi; Laura Caputo; Pyapalli Rani; DuPont Guerry; Emma Furth; Barrett J Rollins; Mary Putt; Phyllis Gimotty; Rolf Swoboda; Meenhard Herlyn; Dorothee Herlyn
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

8.  Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.

Authors:  W J Lane; S Dias; K Hattori; B Heissig; M Choy; S Y Rabbany; J Wood; M A Moore; S Rafii
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

9.  Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1.

Authors:  M Brauchle; D Glück; F Di Padova; J Han; H Gram
Journal:  Exp Cell Res       Date:  2000-07-10       Impact factor: 3.905

10.  Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines.

Authors:  A Janowska-Wieczorek; L A Marquez; A Dobrowsky; M Z Ratajczak; M L Cabuhat
Journal:  Exp Hematol       Date:  2000-11       Impact factor: 3.084

View more
  17 in total

1.  α2β1 Integrin Is Required for Optimal NK Cell Proliferation during Viral Infection but Not for Acquisition of Effector Functions or NK Cell-Mediated Virus Control.

Authors:  Colby Stotesbury; Pedro Alves-Peixoto; Brian Montoya; Maria Ferez; Savita Nair; Christopher M Snyder; Shunchuan Zhang; Cory J Knudson; Luis J Sigal
Journal:  J Immunol       Date:  2020-02-03       Impact factor: 5.422

2.  Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

Authors:  Stacey L Hembruff; Nikki Cheng
Journal:  Cancer Ther       Date:  2009-04-14

3.  Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.

Authors:  P Elumalai; A Brindha Mercy; R Arunkamar; G Sharmila; F A Bhat; S Balakrishnan; P Raja Singh; J Arunakaran
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

4.  Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT.

Authors:  Karin Edsparr; Frank M Speetjens; Adri Mulder-Stapel; Ronald H Goldfarb; Per H Basse; Bo Lennernäs; Peter J K Kuppen; Per Albertsson
Journal:  J Immunother       Date:  2010-06       Impact factor: 4.456

5.  CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis.

Authors:  Xian-Ming Xia; Fang-Yu Wang; Wen-An Xu; Zhen-Kai Wang; Jiong Liu; You-Ke Lu; Xin-Xin Jin; Heng Lu; Yun-Zhu Shen
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

6.  Combined treatment with a CXCL12 analogue and antibiotics improves survival and neutrophil recruitment and function in murine sepsis.

Authors:  Shuwen Guan; Changrun Guo; Basilia Zingarelli; Liping Wang; Perry V Halushka; James A Cook; Hongkuan Fan
Journal:  Immunology       Date:  2014-09-08       Impact factor: 7.397

Review 7.  Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.

Authors:  Hamid Khodayari; Saeed Khodayari; Elmira Ebrahimi; Farimah Hadjilooei; Miko Vesovic; Habibollah Mahmoodzadeh; Tomo Saric; Wilfried Stücker; Stefaan Van Gool; Jürgen Hescheler; Karim Nayernia
Journal:  Cancer Immunol Immunother       Date:  2021-07-04       Impact factor: 6.968

8.  Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models.

Authors:  Kyung Eun Sung; Xiaojing Su; Erwin Berthier; Carolyn Pehlke; Andreas Friedl; David J Beebe
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

9.  Exercise-induced up-regulation of MMP-1 and IL-8 genes in endurance horses.

Authors:  Katia Cappelli; Michela Felicetti; Stefano Capomaccio; Camillo Pieramati; Maurizio Silvestrelli; Andrea Verini-Supplizi
Journal:  BMC Physiol       Date:  2009-06-24

10.  CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression.

Authors:  Xiaojuan Sun; Lei Wei; Qian Chen; Richard M Terek
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.